Oral e-Poster Presentations - Booth 3: Neuro-Oncology A (Malignant glioma)
Tracks
Ground Floor
| Monday, September 25, 2023 |
| 1:00 PM - 2:30 PM |
| Ground floor - Booth 3 |
Details
Oral e-Posters: 3 minutes presentation duration
Speakers & Chairs
Dr Hanne-Rinck Jeltema
Neurosurgeon
UMCG
Chair
Dr Felix Behling
Associate Professor
University Hospital Tübingen
Chair
Ms Dina Abo-elnour
Undergraduate Medical Student
Zagazig University
Awake versus asleep motor mapping for glioma resection: a systematic review and meta-analysis
Dr Emily Rose Bligh
Academic Foundation Doctor
Queen Elizabeth University Hospital, Glasgow
Imaging Timing After Surgery for Glioblastoma (INTERVAL GB): A multi-centre, UK and Ireland retrospective cohort study
Dr Luca Francesco Salvati
Consultant Neurosurgeon
Asl2 Liguria- Santa Corona Hospital
Opening the lateral ventricle in glioblastoma surgery: a risk worth taking?
Mr James Morris
Student Doctor
Cambridge University Hospital NHS Foundation Trust
Parametric Analysis Of Survival Data In Patients With Malignant Glioma Indicates A Dramatic Improvement In Overall Survival With Temozolomide Therapy Regardless Of MGMT Methylation
Dr Maximilian Scheer
Resident
University Hospital Halle
Synergistic Effects of Combining Tumor Treating Fields with Nimodipine in Glioma Cells
Dr Vera Nickl
Resident
Universität Würzburg
Co-Culture of PBMCs and Patient Derived Organoids Enhances Glioblastoma Tumor Microenvironment
Dr Marta Bonada
Turin
università degli studi di Torino
Deep Learning Based Algorithm For Postoperative Glioblastoma MRI Segmentation: A Promising New Tool For Tumor Burden Assessment
Prof Malgorzata Kolodziej
Consultant
Justus-liebig-university Giessen
FTY720 increases sensitivity of Temozolomid due to down-regulation of N-Cadherin expression in glioblastoma cells
Mr Andrii Dashchakovskyi
Neurosurgeon
State Institution “Romodanov Neurosurgery Institute, National Academy Of Medical Sciences Of Ukraine”
Photodynamic Effects of Chlorine E6 and Laser Irradiation on U251 Glioblastoma Cells Viability in Vitro
Ms Leonie Kram
Phd Student, Research Assistant
Klinikum rechts der Isar, Technical University Munich, Germany
Functionally Relevant Left-hemispheric Cortical and Subcortical Correlates of Receptive Aphasia in High Grade Glioma Patients
Dr Harald Krenzlin
Attending
University Medical Center Mainz
CMV infection in glioblastoma - Oncomodulation through changes to the glioma immune landscape
Dr Celine Iswarya Partha Sarathi
Foundation Year Doctor
SWBH Nhs Trust
Personalised Therapeutic Approaches to Glioblastoma: A Systematic Review
Dr Harald Krenzlin
Attending
University Medical Center Mainz
The role of surgery in IDH wildtype diffuse astrocytomas
Dr Harald Krenzlin
Attending
University Medical Center Mainz
Longitudinal analysis of the immune landscape in recurrent glioblastoma – Infiltration of Natural killer cells and TCR clonality as biomarkers of overall survival
Dr Alice Dauth
Resident
University Medical Center of Johannes Gutenberg-University Mainz
Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?
Dr Ayoub Saaid
Training Doctor
University Of Turin
Comparison Between Levetiracetam And Lacosamide In Glioblastoma Setting: Impact On Survival And Seizure Control
Dr Tomasz Dziedzic
Consultant Neurosurgeon
Medical University Of Warsaw
Ischemic changes after glioma surgery: incidence and risk factors.
Dr Anne-Katrin Hickmann
Attending
Kantonsspital St. Gallen
Burden of Affective Symptoms in Patients with High-Grade Gliomas and their Association with Tumor Location and Neurocognitive Deficits
Dr Philipp Karschnia
Resident Physician
Ludwig-Maximilians-University Munich
Extent Of Resection In Glioblastoma: Refinement And Prognostic Validation Of A Novel RANO Classification System From The RANO Resect Group
Prof Georgios Alexiou
Associate Professor
University Of Ioannina
Assessment of glioma grade of malignancy and extent of resection using intraoperative flow cytometry
Dr Antti Pekka Elomaa
Neurosurgeon, Associate Professor
Kuopio University Hospital
Intraoperative aspirate tissue monitoring during 5-ALA fluorescence-guided surgery of high-grade glioma – the first-in-human observational cases
Dr Giada Garufi
Md
Azienda Ospedaliera Papardo Messina
Minimized photobleaching in 5-ALA glioblastoma resection with Olympus Orbeye LED light source
Dr Friedrich Erhart
Resident
Medical University of Vienna
Towards precision cancer medicine: personalized zebrafish avatars for high-grade glioma treatment optimization (PECAZA)
Dr Dominik Koessinger
Specialist Registrar
Freiburg University Hospital
Ventricular opening during primary and recurrent glioblastoma surgery - a single centre study
